Works by Kim, Won


Results: 5000
    1

    Pairwise analysis of plasma cell-free DNA before and after palliative second-line paclitaxel plus ramucirumab treatment in patients with metastatic gastric cancer.

    Published in:
    Gastric Cancer, 2025, v. 28, n. 4, p. 620, doi. 10.1007/s10120-025-01604-y
    By:
    • Kim, Ji-Won;
    • Kyung, Dong Soo;
    • Ko, Won Yeong;
    • Kim, Hwang-Phill;
    • Hwang, Sung-Hyun;
    • Kim, Kui-Jin;
    • Lee, Ju Hyun;
    • Seo, Jeongmin;
    • Kang, Minsu;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Kim, Se Hyun;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Lee, Keun-Wook
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2995, doi. 10.1007/s00432-021-03872-4
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    40
    41

    Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
    By:
    • Kim, Hye In;
    • Kim, Won Gu;
    • Kim, Mijin;
    • Ko, Nak Gyeong;
    • Jin, Mihyeon;
    • Jung, Hyun Ae;
    • Sun, Jong-Mu;
    • Ahn, Jin Seok;
    • Ahn, Myung-Ju;
    • Choi, Yoon-La;
    • Jeon, Min Ji;
    • Kim, Tae Yong;
    • Kim, Won Bae;
    • Kim, Sang-We;
    • Lee, Dae Ho;
    • Jang, Se Jin;
    • Kim, Sun Wook;
    • Chung, Jae Hoon;
    • Kim, Tae Hyuk;
    • Lee, Se-Hoon
    Publication type:
    Article
    42

    Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
    By:
    • Kim, Hye In;
    • Kim, Won Gu;
    • Kim, Mijin;
    • Ko, Nak Gyeong;
    • Jin, Mihyeon;
    • Jung, Hyun Ae;
    • Sun, Jong-Mu;
    • Ahn, Jin Seok;
    • Ahn, Myung-Ju;
    • Choi, Yoon-La;
    • Jeon, Min Ji;
    • Kim, Tae Yong;
    • Kim, Won Bae;
    • Kim, Sang-We;
    • Lee, Dae Ho;
    • Jang, Se Jin;
    • Kim, Sun Wook;
    • Chung, Jae Hoon;
    • Kim, Tae Hyuk;
    • Lee, Se-Hoon
    Publication type:
    Article
    43
    44

    Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03197-9
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    45
    46
    47
    48
    49
    50